LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $28,661,000 | +3.7% | 270,794 | -0.4% | 0.02% | 0.0% |
Q4 2016 | $27,635,000 | +30.4% | 271,970 | +31.0% | 0.02% | +27.8% |
Q3 2016 | $21,196,000 | -14.4% | 207,684 | -0.0% | 0.02% | -14.3% |
Q2 2016 | $24,775,000 | +13.0% | 207,721 | +1.4% | 0.02% | +10.5% |
Q1 2016 | $21,932,000 | -2.4% | 204,796 | -1.2% | 0.02% | 0.0% |
Q4 2015 | $22,466,000 | -44.7% | 207,214 | -56.3% | 0.02% | +5.6% |
Q3 2015 | $40,604,000 | +101.0% | 474,076 | +136.7% | 0.02% | +5.9% |
Q2 2015 | $20,206,000 | +239.9% | 200,258 | +159.7% | 0.02% | +240.0% |
Q1 2015 | $5,945,000 | – | 77,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $8,459 | 3.32% |
VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |